EMEA-002515-PIP01-18
Table of contents
Key facts
| Active substance |
Human immunoglobulin G2 isotype antibody to IL-33R
|
| Therapeutic area |
Pneumology-allergology
|
| Decision number |
P/0055/2020
|
| PIP number |
EMEA-002515-PIP01-18
|
| Pharmaceutical form(s) |
Powder for solution for injection
|
| Condition(s) / indication(s) |
Treatment of asthma
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
GlaxoSmithKline Trading Services Limited
Tel. +1 4388998201 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|